Cardizem and Infusion site extravasation - from FDA reports


Summary

Infusion site extravasation is found among people who take Cardizem, especially for people who are female, 60+ old also take medication Lasix, and have Colorectal cancer metastatic. This review analyzes which people have Infusion site extravasation with Cardizem. It is created by eHealthMe based on reports of 20,995 people who have side effects when taking Cardizem from FDA , and is updated regularly.

What to expect?

If you take Cardizem and have Infusion site extravasation, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Cardizem and have Infusion site extravasation

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Sep, 17, 2017

20,995 people reported to have side effects when taking Cardizem.
Among them, 9 people (0.04%) have Infusion site extravasation


Number of reports submitted per year:

Could Cardizem cause Infusion site extravasation?

Gender of people who have Infusion site extravasation when taking Cardizem *:

  • female: 55.56 %
  • male: 44.44 %

Age of people who have Infusion site extravasation when taking Cardizem *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Top conditions involved for these people *:

  • Colorectal Cancer Metastatic (2 people, 22.22%)
  • Sleep Disorder (1 person, 11.11%)
  • Migraine (1 person, 11.11%)
  • Metastatic Gastric Cancer (1 person, 11.11%)
  • Crohn's Disease (1 person, 11.11%)

Top co-used drugs for these people *:

  • Synthroid (3 people, 33.33%)
  • Lasix (3 people, 33.33%)
  • Mucinex (2 people, 22.22%)
  • Magnesium (2 people, 22.22%)
  • Crestor (2 people, 22.22%)

Top other side effects for these people *:

  • Infusion Site Pain (2 people, 22.22%)
  • Fluid Overload (2 people, 22.22%)
  • Fall (2 people, 22.22%)
  • Staphylococcal Skin Infection (1 person, 11.11%)
  • Agitation (1 person, 11.11%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Infusion site extravasation when taking Cardizem?

Expand the study to include all drugs with the same ingredients

Infusion site extravasation and drugs with ingredients of diltiazem hydrochloride.

Expand the study to include reports from both FDA and eHealthMe

Infusion site extravasation and Cardizem from FDA and eHealthMe reports

Cardizem

Cardizem has active ingredients of diltiazem hydrochloride. It is often used in high blood pressure. (latest outcomes from Cardizem 21,792 users)

Infusion site extravasation

Infusion site extravasation (flow of (blood or lymph) from infusion site) has been reported by people with multiple sclerosis, immunodeficiency common variable, rheumatoid arthritis, crohn's disease, osteoporosis (latest reports from 1,942 Infusion site extravasation patients).

Browse all side effects of Cardizem

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Infusion site extravasation

Infusion site extravasation

Could your condition cause Infusion site extravasation

Infusion site extravasation

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Cardizem and have Infusion site extravasation.

User reviews to the study

More reviews >